Related references
Note: Only part of the references are listed.PD-1 antibody and ruxolitinib enhances graft-versus-lymphoma effect without increasing acute graft-versus-host disease in mice
Bin Pan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Dynamic of plasma IL-22 level is an indicator of thymic output after allogeneic hematopoietic cell transplantation
Longmei Shang et al.
LIFE SCIENCES (2021)
IFN-γ-Stimulated Apoptotic Keratinocytes Promote Sclerodermatous Changes in Chronic Graft-Versus-Host Disease
Akimasa Saito et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation
Yoshihiro Inamoto et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease
Gerard Socie et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies
Kirk R. Schultz et al.
BLOOD (2020)
The immune landscape and response to immune checkpoint blockade therapy in lymphoma
Justin Kline et al.
BLOOD (2020)
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
Juan C. Nieto et al.
LEUKEMIA (2020)
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD
Bruce R. Blazar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation
Takaaki Konuma et al.
CLINICAL CANCER RESEARCH (2020)
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation
Awais Ijaz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles
Daping Yang et al.
IMMUNITY (2019)
Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease
Tomohiro Yamakawa et al.
BLOOD (2018)
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance
Justin Kale et al.
EMBO REPORTS (2018)
PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells
Xiong Ni et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
Charles Herbaux et al.
BLOOD (2017)
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy
Takeru Asano et al.
BLOOD (2017)
Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution
Coco de Koning et al.
BLOOD (2016)
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8+ Cytolytic T Cell Responses
Alison Taylor et al.
IMMUNITY (2016)
Genetic and Epigenetic Regulation of PD-1 Expression
Alexander P. R. Bally et al.
JOURNAL OF IMMUNOLOGY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment
Jing Li et al.
CANCER RESEARCH (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Programmed Death-1 Pathway in Host Tissues Ameliorates Th17/Th1-Mediated Experimental Chronic Graft-versus-Host Disease
Hideaki Fujiwara et al.
JOURNAL OF IMMUNOLOGY (2014)
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis
M. Stern et al.
LEUKEMIA (2014)
Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
S Pugazhenthi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)